Zdrowie i gospodarka · 10/11/2009
FDA Extends Comment Period for Combination Product CGMP Requirements
The Food and Drug Administration (FDA) has extended the comment period for proposed rules on current good manufacturing practice (CGMP) requirements for combination products until February 5, 2010, in response to requests for an extension.
Source: Federal Register — Food and Drug AdministrationOpen original release →